The risk transfer shell game

Credit derivatives

The UK’s Financial Services Authority (FSA) caused a storm of controversy in January, when chairman Howard Davies quoted an unnamed investment banker as saying that synthetic collateralised debt obligations (CDOs) were “the most toxic element of the financial markets today”. In May, the FSA officially backed away from those comments, but the focus on insurance companies’ use of credit derivatives by national and international regulatory bodies looks likely to continue for some time.


Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: